Fresh Tracks Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Fresh Tracks Therapeutics

10/11/2022 23:18

* Fresh Tracks Therapeutics Inc  FRTX.OQ  reported a
quarterly
adjusted loss of $2.07​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of $1.89 per share.
    * Revenue rose 268.2% to $486.00 thousand from a year ago;
analysts expected $430.00 thousand. 
    * Fresh Tracks Therapeutics Inc's reported EPS for the
quarter was
a loss of $2.07​.
    * The mean earnings estimate of analysts had risen by
about 8.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Fresh Tracks Therapeutics Inc shares had fallen by 3.4%
this
quarter and lost 83.2% so far this year.
    * The company reported a quarterly loss of $6.02 million.
    * Wall Street's median 12-month price target for Fresh
Tracks
Therapeutics Inc is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:18 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.89          -2.07          Missed
 Jun. 30 2022      -1.44          -0.01          Beat
 Mar. 31 2022      -2.59          -3.60          Missed
 Dec. 31 2021      -3.82          -2.70          Beat